| Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer K Gondkar, G Sathe, N Joshi, B Nair, A Pandey, P Kumar Cells 10 (3), 511, 2021 | 10 | 2021 |
| Proteomic Signatures of Diffuse and Intestinal Subtypes of Gastric Cancer S Singh, MY Bhat, G Sathe, C Gopal, J Sharma, AK Madugundu, NS Joshi, ... Cancers 13 (23), 5930, 2021 | 10 | 2021 |
| A Proteomic Study to Unveil Lead Toxicity-Induced Memory Impairments Invoked by Synaptic Dysregulation N Mohanraj, NS Joshi, R Poulose, RR Patil, R Santhoshkumar, A Kumar, ... Toxicology Reports, 2022 | 3 | 2022 |
| Automated Sample Preparation Workflow for Tandem Mass Tag-Based Proteomics DG Mun, NS Joshi, R Budhraja, GS Sachdeva, T Kang, FA Bhat, H Ding, ... Journal of the American Society for Mass Spectrometry, 2023 | 2 | 2023 |
| Urinary Proteomics for Discovery of Gastric Cancer Biomarkers to Enable Precision Clinical Oncology N Joshi, F Bhat, A Bellad, G Sathe, A Jain, S Chavan, R Sirdeshmukh, ... OMICS: A Journal of Integrative Biology 27 (8), 361-371, 2023 | 2 | 2023 |
| An insight in proteome profiling of Tuta absoluta larvae after entomopathogenic fungal infection GK Bali, SK Singh, VK Chauhan, N Joshi, FA Bhat, WA Malla, ... Scientific data 9 (1), 1-7, 2022 | 2 | 2022 |
| Dysregulated proteome and N‐glycoproteome in ALG1‐deficient fibroblasts R Budhraja, N Joshi, S Radenkovic, T Kozicz, E Morava, A Pandey Proteomics, 2400012, 2024 | 1 | 2024 |
| Recent progress in mass spectrometry-based urinary proteomics N Joshi, K Garapati, V Ghose, RK Kandasamy, A Pandey Clinical Proteomics 21 (1), 14, 2024 | | 2024 |
| A complement C4–derived glycopeptide is a biomarker for PMM2-CDG K Garapati, R Budhraja, M Saraswat, J Kim, N Joshi, GS Sachdeva, A Jain, ... JCI insight 9 (7), 2024 | | 2024 |
| Global O-glycoproteome enrichment and analysis enabled by a combinatorial enzymatic workflow T Kang, R Budhraja, J Kim, N Joshi, K Garapati, A Pandey Cell Reports Methods, 2024 | | 2024 |
| Metabolomic biomarkers for (R, S)‐ketamine and (S)‐ketamine in treatment‐resistant depression and healthy controls: A systematic review R Kumar, NA Nuñez, N Joshi, B Joseph, A Verde, A Seshadri, ... Bipolar Disorders, 2024 | | 2024 |
Akhilesh Pandey, M.D., Ph.D.Professor, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MinnesotaVerified email at mayo.edu
